Skip to main content

Table 1 Clinical information of external test dataset (N = 201)

From: Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases

Type

Category

Number of cases (%)

Sex

Female

199 (99.0%)

Male

2 (1.0%)

Age group

 ≤ 40

14 (7.0%)

41–50

55 (27.4%)

51–60

50 (24.9%)

61–70

49 (24.4%)

 ≥ 71

33 (16.4%)

Specimen

Biopsy

12 (6.0%)

Surgical excision

189 (94.0%)

Stage

1A

90 (44.8%)

1B

1 (0.5%)

2A

56 (27.9%)

2B

23 (11.4%)

3A

16 (8.0%)

3B

1 (0.5%)

3C

8 (4.0%)

4

6 (3.0%)